| License: Creative Commons Attribution 4.0 PDF - Published Version (8MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-750873
- DOI to cite this document:
- 10.5283/epub.75087
Abstract
Background and Objectives: Aberrant upregulation of fatty acid synthase (FASN), catalyzing de novo synthesis of fatty acids, occurs in various tumor types, including human hepatocellular carcinoma (HCC). Although FASN oncogenic activity seems to reside in its pro-lipogenic function, cumulating evidence suggests that FASN’s tumor-supporting role might also be metabolic-independent. Materials ...

Owner only: item control page

Download Statistics